Point72 Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.8M Buy
424,750
+406,751
+2,260% +$70.3M 0.12% 250
2025
Q4
$3.29M Sell
17,999
-715
-4% -$99.8K 0.01% 2137
2025
Q3
$2.27M Sell
18,714
-332,259
-95% -$37.4M ﹤0.01% 1387
2025
Q2
$36.6M Buy
350,973
+224,780
+178% +$23.8M 0.09% 313
2025
Q1
$14.7M Sell
126,193
-58,945
-32% -$6.72M 0.04% 539
2024
Q4
$15.7M Sell
185,138
-357,482
-66% -$32.9M 0.04% 543
2024
Q3
$48.8M Buy
542,620
+63,576
+13% +$5.55M 0.17% 195
2024
Q2
$38.6M Buy
479,044
+100,180
+26% +$7.42M 0.12% 266
2024
Q1
$30.2M Sell
378,864
-458,337
-55% -$38.5M 0.09% 322
2023
Q4
$66.6M Buy
837,201
+305,264
+57% +$20.4M 0.2% 162
2023
Q3
$37.2M Buy
531,937
+63,934
+14% +$4.78M 0.13% 239
2023
Q2
$33.6M Sell
468,003
-701,824
-60% -$51.8M 0.12% 255
2023
Q1
$72.2M Buy
1,169,827
+519,762
+80% +$34.1M 0.26% 114
2022
Q4
$50.1M Buy
650,065
+32,165
+5% +$1.92M 0.19% 152
2022
Q3
$27.6M Buy
617,900
+576,125
+1,379% +$28.8M 0.12% 247
2022
Q2
$1.6M Buy
+41,775
New +$1.32M 0.01% 986
2021
Q2
Sell
-42,300
Closed -$2.4M 970
2021
Q1
$2.4M Sell
42,300
-35,200
-45% -$2.48M 0.01% 708
2020
Q4
$6.31M Sell
77,500
-13,157
-15% -$984K 0.03% 543
2020
Q3
$6.46M Sell
90,657
-168,740
-65% -$13.1M 0.04% 506
2020
Q2
$21.3M Sell
259,397
-424,857
-62% -$32.7M 0.15% 207
2020
Q1
$40.3M Buy
+684,254
New +$55.8M 0.34% 78
2019
Q4
Sell
-160,000
Closed -$3.24M 961
2019
Q3
$3.24M Buy
+160,000
New +$4.11M 0.02% 526
2019
Q1
Sell
-250,000
Closed -$705K 1021
2018
Q4
$705K Buy
+250,000
New +$823K ﹤0.01% 849

Other funds holding AXSM